EUVIMEDEUVIMED entdecken
Crossref

Gallium Protoporphyrin and Lipid Crystalline Nanoparticles Promote the Activity of Ampicillin against MRSA

Muhammed Awad iD, Sholeh Feizi, Peter-John Wormald, Alkis J Psaltis, Sarah Vreugde iD

ACS Infectious Diseases · 12.06.2026 · 12 (6) · 2114-2123

DOI: 10.1021/acsinfecdis.6c00202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 28.05.2026. Verfasst von Muhammed Awad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, …. Hauptthemen laut MEDLINE: Ampicillin, Anti-Bacterial Agents, Gallium, Methicillin-Resistant Staphylococcus aureus. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Health and Medical Research Council, Garnett Passe and Rodney Williams Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Promoting the effectiveness of antibiotics against multidrug-resistant bacteria is necessary to overcome the global antimicrobial resistance crisis. Methicillin-resistant Staphylococcus aureus (MRSA) is notorious for its β-lactam resistance and high antibiotic tolerance, due to its ability to grow intracellularly and as biofilms. Herein, we investigated the potential to promote the activity of ampicillin (AMP) against MRSA by incorporation of AMP alone or in combination with gallium protoporphyrin (GaPP) into lipid liquid crystalline nanoparticles (LCNP). The three unimodal dispersions of AMP-LCNP, GaPP-LCNP, and GaPP/AMP-LCNP had an average diameter range between (175-250 nm) and PDI 100-fold; eradicated MRSA intracellular infection and significantly reduced the viability of MRSA biofilms by 5.5 and 8 log10. The data highlights the success of dual-loading synergistic antimicrobials in LCNP to promote the antibacterial activity against MRSA in different growth modes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmpicillinAnti-Bacterial AgentsGalliumMethicillin-Resistant Staphylococcus aureusNanoparticlesProtoporphyrinsbeta Lactam AntibioticsBiofilmsDrug SynergismLiposomesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

MRSAampicillinbiofilmsliquid crystalline nanoparticlesβ lactam resistance

Substanzen

AmpicillinAnti-Bacterial Agentsbeta Lactam AntibioticsGalliumLipid NanoparticlesLiposomesProtoporphyrins

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Health Network, Adelaide 5011, Australia.
  • The Department of Surgery, School of Medicine, Adelaide University, Adelaide 5000, Australia.

ORCID-Profile: Muhammed Awad, Sarah Vreugde

Förderung

  • National Health and Medical Research Council
  • Garnett Passe and Rodney Williams Memorial Foundation

Zitieren

APA

Awad, M., Feizi, S., Wormald, P. J., Psaltis, A. J., & Vreugde, S. (2026). Gallium Protoporphyrin and Lipid Crystalline Nanoparticles Promote the Activity of Ampicillin against MRSA. ACS Infectious Diseases, 12(6), 2114-2123. https://doi.org/10.1021/acsinfecdis.6c00202

Vancouver

Awad M, Feizi S, Wormald PJ, Psaltis AJ, Vreugde S. Gallium Protoporphyrin and Lipid Crystalline Nanoparticles Promote the Activity of Ampicillin against MRSA. ACS Infectious Diseases. 2026;12(6):2114-2123. doi:10.1021/acsinfecdis.6c00202

BibTeX
@article{Awad2026,
  author = {Awad, Muhammed and Feizi, Sholeh and Wormald, Peter-John and Psaltis, Alkis J and Vreugde, Sarah},
  title = {Gallium Protoporphyrin and Lipid Crystalline Nanoparticles Promote the Activity of Ampicillin against MRSA},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {6},
  pages = {2114--2123},
  doi = {10.1021/acsinfecdis.6c00202}
}
Kostenlos starten →